FDA offers guidance on expectations and procedures to conduct voluntary remote interactive evaluations at manufacturing. Included are FDA’s bioresearch monitoring (BIMO) program; and outsourcing facilities registered under section 503B of the Federal Food, Drug, and Cosmetic Act (FD&C Act). These guidelines are available directly from the FDA website using
this link.